Dongwu Securities released a research report on April 17 stating that it gave Covex shares (300856.SZ) a purchase rating. The main reasons for the rating include: 1) continued high performance growth in 2023 and 2024Q1; 2) profitability remained high and cost control was good; 3) smooth and continuous expansion of new products, and structural product upgrades continuously driven profitability optimization; 4) the gradual release of production capacity for new cosmetic raw products, and the layout of overseas production capacity to open a new chapter in global production. (Mainichi Keizai Shimbun)
东吴证券4月17日发布研报称，给予科思股份（300856.SZ）买入评级。评级理由主要包括：1）2023年及2024Q1业绩持续高增；2）盈利能力维持高位，费用管控较好；3）新产品拓展顺利持续放量，结构性产品升级不断驱动盈利能力优化；4）化妆品原料新产品产能规模逐步释放，布局海外产能开启全球化生产新篇章。（每日经济新闻）
Dongwu Securities released a research report on April 17 stating that it gave Covex shares (300856.SZ) a purchase rating. The main reasons for the rating include: 1) continued high performance growth in 2023 and 2024Q1; 2) profitability remained high and
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.